COCIR and HIMSS strengthen their cooperation

Published on:

BRUSSELS – 22 June 2015 – The European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR*) and the Healthcare Information and Management Systems Society (HIMSS**) have renewed their cooperation agreement to progress their common goal of improving the use of information and management systems for the betterment of healthcare.

Since the agreement was initially signed in 2008, COCIR and HIMSS have cooperated through a number of events including eHealth Week as well through COCIR’s first eHealth Summit last year.

Collectively representing various stakeholders in the health ICT field, with some industries holding memberships in both organisations, COCIR and HIMSS are committed to advancing the best use of information and management systems for improving healthcare systems.

H. Stephen Lieber, HIMSS President and CEO, said: ”With this MoU, HIMSS’ cooperation with COCIR has been reinforced and we look forward to continuing jointly ensuring adequate information is available for stakeholders so that positive policy decisions are made to improve healthcare access quality as well as improving the efficiency of healthcare systems and driving patient outcomes.”

Joost Leeflang, COCIR President, stated, “The collaboration between COCIR and HIMSS has successfully raised awareness to European decision-makers on the important role of the health ICT sector in centralising best practices and focusing on deployment. We look forward to continuing our joint efforts transforming healthcare, towards seamless integrated care and executing projects at European, regional and national levels”.

 

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.